These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19060551)

  • 21. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
    Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N
    Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of renal dysfunction in the liver transplant recipient.
    Pham PT; Pham PC; Wilkinson AH
    Curr Opin Organ Transplant; 2009 Jun; 14(3):231-9. PubMed ID: 19395967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Operational tolerance: past lessons and future prospects.
    Levitsky J
    Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Our evolving understanding of late kidney allograft failure.
    Gaston RS
    Curr Opin Organ Transplant; 2011 Dec; 16(6):594-9. PubMed ID: 21971511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid-free maintenance immunosuppression and ABO-incompatible transplantation.
    Gloor J; Matas AJ
    Transplantation; 2010 Mar; 89(6):648-9. PubMed ID: 20010327
    [No Abstract]   [Full Text] [Related]  

  • 26. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
    Yang H
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence.
    Camilleri B; Bridson JM; Halawa A
    Exp Clin Transplant; 2016 Oct; 14(5):471-483. PubMed ID: 27213490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring the operationally tolerant liver allograft recipient.
    Castellaneta A; Thomson AW; Nayyar N; de Vera M; Mazariegos GV
    Curr Opin Organ Transplant; 2010 Feb; 15(1):28-34. PubMed ID: 19890211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Controversies about the use of calcineurin inhibitors in pediatric patients].
    Dello Strologo L
    G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive strategies to improve outcomes of kidney transplantation.
    Tang IY; Meier-Kriesche HU; Kaplan B
    Semin Nephrol; 2007 Jul; 27(4):377-92. PubMed ID: 17616271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte markers and prediction of long-term renal allograft acceptance.
    Babel N; Reinke P; Volk HD
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):489-94. PubMed ID: 19724222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressors].
    Sánchez-Fructuoso AI
    Nefrologia; 2008; 28 Suppl 5():21-5. PubMed ID: 18847416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney transplantation and pregnancy.
    Zachariah MS; Tornatore KM; Venuto RC
    Curr Opin Organ Transplant; 2009 Aug; 14(4):386-91. PubMed ID: 19512929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rejection and acceptance of corneal allografts.
    Klebe S; Coster DJ; Williams KA
    Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
    Hesselink DA; Bouamar R; van Gelder T
    Ther Drug Monit; 2010 Aug; 32(4):387-93. PubMed ID: 20571464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimization of immunosuppression in kidney transplantation.
    Augustine JJ; Hricik DE
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of third kidney transplants.
    Loupy A; Anglicheau D; Suberbielle C; Méjean A; Martinez F; Zuber J; Mamzer-Bruneel MF; Kreis H; Thervet E; Thiounn N; Legendre C
    Nephrol Dial Transplant; 2007 Sep; 22(9):2693-700. PubMed ID: 17452406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic calcineurin inhibitor use is nephrotoxic.
    Chapman JR
    Clin Pharmacol Ther; 2011 Aug; 90(2):207-9. PubMed ID: 21772296
    [No Abstract]   [Full Text] [Related]  

  • 40. Pretransplant immune risk assessment.
    Sawitzki B; Schlickeiser S; Reinke P; Volk HD
    Curr Opin Organ Transplant; 2009 Dec; 14(6):650-5. PubMed ID: 19779344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.